STAT+: Amgen’s rheumatoid arthritis drug Enbrel targeted for first-in-the-nation price limit in Colorado

Colorado moves to cap the price of Etanercept, an autoimmune drug sold by Amgen under the brand name Enbrel, in drive to lower prescription drug prices.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks